IRHYTHM TECHNOLOGIES INC

NASDAQ: IRTC (iRhythm Technologies, Inc.)

Last update: 01 Jan, 11:20PM

177.44

-1.13 (-0.63%)

Previous Close 178.57
Open 178.69
Volume 149,022
Avg. Volume (3M) 435,579
Market Cap 5,716,964,864
Price / Sales 8.12
Price / Book 47.43
52 Weeks Range
86.99 (-50%) — 212.00 (19%)
Earnings Date 30 Oct 2025
Profit Margin -15.90%
Operating Margin (TTM) -19.49%
Diluted EPS (TTM) -3.12
Quarterly Revenue Growth (YOY) 20.30%
Total Debt/Equity (MRQ) 848.67%
Current Ratio (MRQ) 5.71
Operating Cash Flow (TTM) 47.53 M
Levered Free Cash Flow (TTM) 26.95 M
Return on Assets (TTM) -4.37%
Return on Equity (TTM) -111.13%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock iRhythm Technologies, Inc. Bullish Bullish

AIStockmoo Score

1.3
Analyst Consensus 4.0
Insider Activity NA
Price Volatility -3.5
Technical Moving Averages 2.5
Technical Oscillators 2.0
Average 1.25

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
IRTC 6 B - - 47.43
TMDX 4 B - 49.96 11.80
ESTA 2 B - - 129.49
PRCT 2 B - - 4.52
UFPT 2 B - 25.58 4.24
IRMD 1 B 1.23% 58.32 12.72

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Sector Healthcare
Industry Medical Devices
Investment Style Small Growth
% Held by Insiders 1.08%
% Held by Institutions 115.08%
52 Weeks Range
86.99 (-50%) — 212.00 (19%)
Price Target Range
202.00 (13%) — 244.00 (37%)
High 244.00 (Needham, 37.51%) Buy
Median 215.00 (21.17%)
Low 202.00 (Goldman Sachs, 13.84%) Hold
Average 220.56 (24.30%)
Total 8 Buy, 1 Hold
Avg. Price @ Call 183.41
Firm Date Target Price Call Price @ Call
Needham 12 Jan 2026 244.00 (37.51%) Buy 179.43
31 Oct 2025 244.00 (37.51%) Buy 187.30
Evercore ISI Group 05 Jan 2026 210.00 (18.35%) Buy 184.39
Truist Securities 18 Dec 2025 215.00 (21.17%) Buy 168.48
15 Oct 2025 205.00 (15.53%) Buy 175.67
Morgan Stanley 02 Dec 2025 205.00 (15.53%) Buy 181.87
BTIG 31 Oct 2025 215.00 (21.17%) Buy 187.30
13 Oct 2025 195.00 (9.90%) Buy 177.37
Canaccord Genuity 31 Oct 2025 212.00 (19.48%) Buy 187.30
Citigroup 31 Oct 2025 242.00 (36.38%) Buy 187.30
Goldman Sachs 31 Oct 2025 202.00 (13.84%) Hold 187.30
JP Morgan 31 Oct 2025 240.00 (35.26%) Buy 187.30
Show more

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria